IMI (IMI) Q3 2025 TU earnings summary

Executive summary

• Organic revenue grew 12% year-over-year in Q3 and is up 5% year-to-date, reflecting strong execution and growth strategy success.

• Full-year guidance for mid-single-digit organic revenue growth reconfirmed, marking the fourth consecutive year of such performance.

• Strong balance sheet and cash generation support ongoing investment, acquisitions, and shareholder returns.

• Process Automation delivered outstanding results, with Q3 sales up 26% year-over-year, driven by shipment phasing and high-margin aftermarket orders.

• Climate Control, Industrial Automation, and Life Science and Fluid Control sectors all performed well, with notable catch-up shipments in Life Science and Fluid Control.

Financial highlights

• Q3 statutory revenue increased 11% year-over-year, with organic revenue up 12%.

• Full-year adjusted basic EPS expected between 129p and 136p.

• Margins expected to reach about 20% for the year, up from 14% in prior years, with a five-year target of 22%.

• Group organic revenue growth of 12% in Q3, with 2–3% attributed to shipment catch-ups, mainly in Life Science and Fluid Control.

• Aftermarket orders in Process Automation up 7% organically year-to-date.

Outlook and guidance

• On track for fourth consecutive year of mid-single-digit organic revenue growth in 2025.

• Full-year guidance reconfirmed despite currency headwinds; exchange rates as of late October 2025 could reduce revenue by 1% and adjusted operating profit by 1.5% for the full year compared to 2024.

• Tax rate to increase to just over 26% next year, impacting EPS by about GBP 0.015.

• Continued investment in cybersecurity following a recent incident, with incremental costs expected.

• Life Sciences expected to return to low single-digit growth next year, with further acceleration anticipated.